Biostar Pharmaceuticals Inc logo

BSPM - Biostar Pharmaceuticals Inc Share Price

$0.2 -0.0  -16.7%

Last Trade - 5:18pm

Sector
Healthcare
Size
Micro Cap
Market Cap £448k
Enterprise Value £1.91m
Revenue £225k
Position in Universe th / 6713
Bullish
Bearish
Unlock BSPM Revenue
Momentum
Relative Strength (%)
1m +266.5%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -20.0%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2011 2012 2013 2014 2015 2016 2017E 2018E CAGR / Avg
92.0 49.3 52.7 61.4 27.1 2.38 -51.8%
-29.2 +2,429
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 30 September 2017, BiostarPharmaceuticals Inc revenues decreased from $2.1M to $0K.Net loss decreased 73% to $2.5M. Revenues reflect adecrease in demand for the Company's products and servicesdue to unfavorable market conditions. Lower net lossreflects Provision for doubtful debt decrease from $7.8M(expense) to $0K, Selling expenses decrease of 67% to $300K(expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

BSPM Revenue Unlock BSPM Revenue

Net Income

BSPM Net Income Unlock BSPM Revenue

Normalised EPS

BSPM Normalised EPS Unlock BSPM Revenue

PE Ratio Range

BSPM PE Ratio Range Unlock BSPM Revenue

Dividend Yield Range

BSPM Dividend Yield Range Unlock BSPM Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
BSPM EPS Forecasts Unlock BSPM Revenue
Profile Summary

Biostar Pharmaceuticals, Inc. (Biostar) is a holding company. The Company, through its subsidiary, Shaanxi Biostar Biotech, Ltd. (Shaanxi Biostar), and its variable interest entities (VIEs), Shaanxi Aoxing Pharmaceutical Co., Ltd. (Aoxing Pharmaceutical) and Shaanxi Weinan Huaren Pharmaceuticals Ltd. (Shaanxi Weinan), develops, manufactures and markets pharmaceutical products for various diseases and conditions in the People's Republic of China (PRC or China). The Company offers over-the-counter (OTC) products and prescription-based pharmaceuticals. The Company's products are sold in approximately 30 provinces in the PRC through a network of over 60 distributors and through approximately 230 sales people. The Company's products include XinAoxing Oleanolic Acid Capsule, Ganwang Compound Paracetamol Capsule, Tianqi Dysmenorrhea Capsule, Compound Paracetamol and Amantadine Hydrochloride Tablets, Deafness Tongqiao pills and Huangyangning Tablets.

Directors
Last Annual December 31st, 2016
Last Interim September 30th, 2017
Incorporated March 27, 2007
Public Since July 9, 2008
No. of Shareholders: n/a
No. of Employees: 438
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange Pink Sheets on Nasdaq
Shares in Issue 2,637,188
Free Float (0.0%)
Eligible for
ISAs
SIPPs
BSPM Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for BSPM
Upcoming Events for BSPM
Frequently Asked Questions for Biostar Pharmaceuticals Inc
What is the Biostar Pharmaceuticals Inc share price?

As of 5:18pm, shares in Biostar Pharmaceuticals Inc are trading at $0.2, giving the company a market capitalisation of £448k. This share price information is delayed by 15 minutes.

How has the Biostar Pharmaceuticals Inc share price performed this year?

Shares in Biostar Pharmaceuticals Inc are currently trading at $0.2 and the price has moved by 0.198k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Biostar Pharmaceuticals Inc price has moved by 0.137k% over the past year.

What are the analyst and broker recommendations for Biostar Pharmaceuticals Inc?

There are no analysts currently covering Biostar Pharmaceuticals Inc.

When will Biostar Pharmaceuticals Inc next release its financial results?

Biostar Pharmaceuticals Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2018-09-30
What is the Biostar Pharmaceuticals Inc dividend yield?

Biostar Pharmaceuticals Inc does not currently pay a dividend.

Does Biostar Pharmaceuticals Inc pay a dividend?

Biostar Pharmaceuticals Inc does not currently pay a dividend.

When does Biostar Pharmaceuticals Inc next pay dividends?

Biostar Pharmaceuticals Inc does not currently pay a dividend.

How do I buy Biostar Pharmaceuticals Inc shares?

To buy shares in Biostar Pharmaceuticals Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Biostar Pharmaceuticals Inc?

Shares in Biostar Pharmaceuticals Inc are currently trading at $0.2, giving the company a market capitalisation of £448k.

Where are Biostar Pharmaceuticals Inc shares listed? Where are Biostar Pharmaceuticals Inc shares listed?

Here are the trading details for Biostar Pharmaceuticals Inc:

Country of listing: United States
Exchange: PNK
Ticker Symbol: BSPM
What kind of share is Biostar Pharmaceuticals Inc?

We were not able to load our ranking data for Biostar Pharmaceuticals Inc

Is there a Biostar Pharmaceuticals Inc share price forecast 2021?

We were not able to load any forecast data for Biostar Pharmaceuticals Inc.

How can I tell whether the Biostar Pharmaceuticals Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Biostar Pharmaceuticals Inc. Over the past six months, the relative strength of its shares against the market has been 0.101k%. At the current price of $0.2, shares in Biostar Pharmaceuticals Inc are trading at 0.141k% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Biostar Pharmaceuticals Inc PE Ratio?

The Biostar Pharmaceuticals Inc PE ratio based on its reported earnings over the past 12 months is 0.61. The shares are currently trading at $0.2.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Biostar Pharmaceuticals Inc?

Biostar Pharmaceuticals Inc's management team is headed by:

Ronghua Wang - CHM
Haipeng Wu - IND
Shuang Gong - SEC
Zhenghong Wang - COO
Xiaojuan Zhai - CFO
Melissa Fan Chen - IND
Huiping Liao - IND
Who are the major shareholders of Biostar Pharmaceuticals Inc?

Here are the top five shareholders of Biostar Pharmaceuticals Inc based on the size of their shareholding:

Inversis Gestión, S.A., SGIIC Investment Advisor
Percentage owned: % (n/a shares)
PanAgora Asset Management Inc. Investment Advisor/Hedge Fund
Percentage owned: % (n/a shares)
Maverick Fund, FI Mutual Fund
Percentage owned: % (n/a shares)
Similar to BSPM
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.